OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company†), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2025. Financial Results Revenue Consolidated revenues for fiscal 2025 were $31.6 million compared to $32.0 million for fiscal 2024. The revenues for fiscal 2025 consisted of $31.4 million in processing and storage fee revenue, $54,000 in product revenue. ...

Core Viewpoint - Cryo-Cell International, Inc. reported a 3% decrease in consolidated revenues for the third quarter of fiscal 2025 compared to the same period in fiscal 2024, indicating potential challenges in revenue generation [1]. Financial Results - Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million, down from $8.07 million in the third quarter of fiscal 2024 [1]. - The company reported a net income figure, although the specific amount was not detailed in the provided text [1].